Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
Outcomes of Geriatric Patients Receiving CD19 Directed CAR-T Therapy: A Single Institution Study | Synapse
March 3, 2026
Outcomes of Geriatric Patients Receiving CD19 Directed CAR-T Therapy: A Single Institution Study
RT
Riya Tandra
Temple University Hospital
CD
Christina C Darwish
NB
Nicholas Barnaba
Temple University Hospital
Ver todo
Puntos clave
Geriatric patients receiving CD19 directed CAR-T therapy showed positive clinical outcomes, enhancing treatment options.
In this study, overall survival rates improved, with 70% of patients achieving a significant response.
Assessment involved retrospective data analysis from a single institution, focusing on patient characteristics and treatment responses.
This highlights the importance of exploring CAR-T therapy in older adults, a population often underrepresented in clinical trials.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Tandra et al. (Sun,) studied this question.
synapsesocial.com/papers/69a760a7c6e9836116a2d9a8
https://doi.org/https://doi.org/10.1016/j.jtct.2025.12.687